Study guide
18.6 Cancer Genetics
PA-CAT Physician Assistant College Admission Test
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 PA-CAT Exam Facts & Overview 1.2 Exam Structure & the Nine-Subject Blueprint 1.3 Registration, Scheduling & Test Day 1.4 Scoring, Transcripts & Study Strategy
2 Chapter 2: Anatomy — Back & Abdomen
2.1 Curvatures of the Vertebral Column 2.2 The Vertebrae 2.3 Spinal Cord and Spinal Nerves 2.4 The Anterior Abdominal Wall 2.5 The Spleen, Esophagus & Stomach 2.6 Intestines, Pancreas, Liver, Biliary Ducts, Hepatic Circulation & Kidney/Ureters
3 Chapter 3: Anatomy — Head, Pelvis & Perineum
3.1 The Skull 3.2 The Face & The Ear 3.3 The Cranial Nerves 3.4 The Bony Pelvis 3.5 The Pelvic Viscera 3.6 Male & Female Perineum and Reproductive Organs
4 Chapter 4: Anatomy — Thorax & Limbs
4.1 Mediastinum & Thoracic Skeletal/Muscular Components 4.2 Lungs, Trachea, Bronchi & Pericardium 4.3 The Heart & Great Vessels 4.4 Pectoral Girdle, Axilla & Brachial Plexus 4.5 Arm, Forearm, Wrist & Hand 4.6 Hip, Thigh, Gluteal Region, Leg, Joints & Foot
5 Chapter 5: Physiology — Cell, Blood & Circulation
5.1 Functions of the Cellular Organelles 5.2 Translation & Transcription 5.3 Hemostasis & Blood Coagulation 5.4 Basics of Flow, Pressure & Resistance 5.5 Microcirculation & Mechanisms of Blood Flow Control 5.6 Cardiac Output, Venous Return & the Lymphatic System 5.7 Coronary Blood Flow
6 Chapter 6: Physiology — Endocrine, GI & Membrane
6.1 Hypothalamus & Pituitary Hormones 6.2 Thyroid & Parathyroid Hormones 6.3 Endocrine & Adrenocortical Hormones 6.4 GI Motility, Secretion, Digestion & Absorption 6.5 Diffusion, Osmosis & Membrane Transport 6.6 Membrane Potential & the Action Potential 6.7 Muscular Contraction & Carbohydrate/Protein/Lipid Metabolism
7 Chapter 7: Physiology — Nervous & Renal
7.1 Nerve Physiology, Conduction & Transmission 7.2 Somatic Sensations, Motor/Cerebral Circuits & the Autonomic Nervous System 7.3 Fluid Balance, Glomerular Filtration & Tubular Reabsorption/Secretion 7.4 Renal Ion & Acid-Base Regulation
8 Chapter 8: Physiology — Respiratory, Reproduction, Heart & Senses
8.1 Pulmonary Ventilation, Gas Exchange & Pulmonary Circulation/Edema 8.2 O2/CO2 Transport & Regulation of Respiration 8.3 Reproduction: Mitosis/Meiosis, Gametogenesis, Pregnancy & Fetal Physiology 8.4 Heart Structure, Cardiac Cycle, Electrical Activity, Heart Defects & Special Senses
9 Chapter 9: Chemistry — Acids, Atoms, Bonding & Gases
9.1 Brønsted-Lowry Acids/Bases, Measuring Acidity & Strengths 9.2 Atomic Theory, Ions & Molecules 9.3 Chemical Bonding & VSEPR Molecular Geometry 9.4 Balancing, Solubility Rules & Types of Reactions 9.5 Oxidation, Reduction & Electrochemistry 9.6 Gas Laws, Dalton's Partial Pressures & Ideal vs Real Gases
10 Chapter 10: Chemistry — Liquids, Stoichiometry, Thermochemistry & Organic I
10.1 Colligative Properties & Factors Affecting Solubility 10.2 Stoichiometry: Conservation of Matter/Energy & Reactant/Product Calculations 10.3 Thermochemistry & Energy in Chemical Changes 10.4 Alkanes & Cycloalkanes 10.5 Bond Properties & Resonance 10.6 Hybridization/LCAO & Stereochemistry
11 Chapter 11: Chemistry — Spectroscopy & Application
11.1 Spectroscopy 11.2 Acid-Base Titrations & Buffer Systems 11.3 Limiting-Reactant & Percent-Yield Calculations 11.4 Electrochemical Cells & Redox Applications 11.5 Organic Reactions & Functional-Group Reactivity 11.6 Spectroscopic Structure Determination
12 Chapter 12: General Biology — Bioenergetics, Cells & Respiration
12.1 Enzymes, Metabolism, Energy & ATP 12.2 Hydrogen/Electron Carriers & Thermodynamics/Free Energy 12.3 Genome Mapping, Characterizing & Sequencing (Biotechnology) 12.4 Cell Structures, Membranous Organelles & Cell Theory 12.5 Eukaryotic Cell Reproduction & Stages of Meiosis 12.6 Cellular Respiration & Fermentation
13 Chapter 13: General Biology — Transport, Building Blocks & Molecules
13.1 Diffusion/Osmosis, Facilitated & Active Transport, Pinocytosis/Phagocytosis 13.2 Chemical Building Blocks: Proteins, Carbohydrates, Carbon, Nucleic Acids & Lipids 13.3 Water, Organization of Matter & Acids/Bases/Salts 13.4 Biological Molecules: DNA Structure, Replication & Repair 13.5 Gene Expression: Regulation, RNA & Protein Degradation
14 Chapter 14: General Biology — RNA, Structure & Signaling
14.1 Types of RNA, tRNA & Ribosomes 14.2 Pre-mRNA Splicing & Eukaryotic Transcription 14.3 Signal Transduction & Intracellular Communication 14.4 Receptor Types & Intracellular Receptors 14.5 G Protein-Coupled Receptor & Receptor Kinase Signaling
15 Chapter 15: Microbiology — Bacteria
15.1 Intracellular Bacteria 15.2 Gram-Positive Cocci & Rods 15.3 Acid-Fast Bacteria 15.4 Gram-Negative Cocci/Coccobacilli & Fermentative/Nonfermenting Rods 15.5 Anaerobic & Spiral-Shaped Bacteria 15.6 Bacterial Role in Disease 15.7 Viruses: HIV & Human Herpesvirus
16 Chapter 16: Microbiology — Viruses, Fungi, Parasites & Host Interaction
16.1 Respiratory, Hepatitis & Gastrointestinal Viruses + Viral Role in Disease 16.2 Fungal Classification, Opportunistic & Cutaneous/Subcutaneous Fungi 16.3 Systemic Dimorphic Fungi 16.4 Parasites: Protozoa & Helminths (Trematodes, Nematodes, Cestodes) 16.5 Parasite Classification & Arthropods 16.6 Principles of Disease, Epidemiology & Microbial Pathogenicity 16.7 Innate/Adaptive Immunity, Pathology/Infection/Disease, Microorganisms & Human Disease, Environmental Microbiology
17 Chapter 17: Genetics — Molecular Structure & Patterns of Inheritance
17.1 Molecular Structure of DNA & RNA 17.2 Chromosome Organization & DNA Replication 17.3 Chromosome Transmission During Cell Division & Sexual Reproduction 17.4 Mendelian & Non-Mendelian Inheritance 17.5 Genetic Linkage & Mapping in Eukaryotes 17.6 Genetic Transfer & Mapping in Bacteria and Bacteriophages
18 Chapter 18: Genetics — Genes, Mutation, Technologies & Medical Genetics
18.1 Molecular Properties of Genes & the Central Dogma 18.2 Mutation: Types & Consequences 18.3 Recombinant DNA & Genetic Technologies 18.4 Gene Regulation in Prokaryotes & Eukaryotes 18.5 Medical Genetics: Mendelian/Chromosomal/Multifactorial Disorders & Screening 18.6 Cancer Genetics 18.7 Population, Developmental & Quantitative Genetics
19 Chapter 19: Behavioral Sciences — Biological Bases of Behavior & Psychology
19.1 Behavioral Neuroscience: Neuroanatomy & Function 19.2 Sensation & Movement 19.3 States of Consciousness 19.4 Learning & Memory 19.5 Cognition, Language & Intelligence 19.6 Psychology: Schools, Development & Personality
20 Chapter 20: Behavioral Sciences — Stress, Research Methods, Sociocultural & Psychological Disorders
20.1 Health, Stress & Coping 20.2 Psychological Research Methods 20.3 Sociocultural Identity & Development 20.4 Psychological Disorders 20.5 Treatment of Psychological Disorders 20.6 Applied & Lifespan Behavioral Science
21 Chapter 21: Biochemistry — Metabolism, Enzymes & Proteins
21.1 Enzymes: Kinetics & Regulation 21.2 Carbohydrate Metabolism 21.3 TCA Cycle, Electron Transport & Oxidative Phosphorylation 21.4 Lipid Metabolism 21.5 Amino Acid & Nitrogen Metabolism + Protein Structure
22 Chapter 22: Biochemistry — Nucleic Acids, Hormones & Lipids
22.1 Nucleic Acids & Nucleotide Biochemistry 22.2 Hormone Biochemistry & Second-Messenger Systems 22.3 Vitamins & Minerals 22.4 Lipid Structure, Membranes & Transport 22.5 Tissue-Specific Biochemistry & Metabolic Integration
23 Chapter 23: Statistics — Anticipating Patterns & Exploring Data
23.1 Exploring & Describing Data 23.2 Probability 23.3 Random Variables & Probability Distributions 23.4 Sampling Distributions & Simulations
24 Chapter 24: Statistics — Sampling, Experimentation & Statistical Inference
24.1 Sampling, Experimentation & Data Collection 24.2 Confidence Intervals 24.3 Hypothesis Testing 24.4 Inference for Comparisons, Chi-Square & Regression
18.6 Cancer Genetics
Key Takeaways Explain This Topic AI
Cancer is a genetic disease of somatic cells in which ~5–10% of cases carry a strong inherited predisposition; the three main gene categories are oncogenes (gain-of-function, dominant), tumor suppressors (loss-of-function, recessive at the cellular level), and mutator/repair genes.
Knudson's two-hit hypothesis requires both alleles of a tumor suppressor to be inactivated — inherited in familial cases, both somatic in sporadic cases.
p53 (guardian of the genome) mediates G1 arrest via p21 after DNA damage and is mutated in ~50% of cancers; BCL-2 overexpression (t(14;18)) blocks apoptosis in follicular lymphoma.
The Hanahan & Weinberg hallmarks include sustained proliferative signaling, evading growth suppressors, resisting apoptosis, replicative immortality, angiogenesis, invasion/metastasis, deregulated energetics, immune evasion, genome instability, and tumor-promoting inflammation.
Key hereditary syndromes: Li-Fraumeni (TP53), familial retinoblastoma (RB1), FAP (APC), Lynch (MMR genes, MSI), hereditary breast/ovarian cancer (BRCA1/2), Cowden (PTEN), VHL, MEN2 (RET).
Last updated: August 2026
Cancer Genetics
Cancer is fundamentally a genetic disease of somatic cells , although about 5–10% of cases carry a strong inherited predisposition. PA-CAT Bulletin of Information, rev. 20240815, Table 8, lists Cancer as part of Medical Genetics and Cancer. The 26-item genetics block commonly tests gene categories, cell-cycle checkpoints, apoptosis, and hereditary syndromes.
Gene Categories
Three categories of cancer genes differ in how mutation changes their function:
Category Normal function Mutation effect Dominance at cellular level Examples
Oncogenes Promote growth (proto-oncogene) Gain-of-function Dominant (one mutant allele suffices) KRAS , MYC , HER2/ERBB2 , BCL-2
Tumor suppressors Restrain growth, repair DNA, induce apoptosis Loss-of-function Recessive (both alleles inactivated) TP53 , RB1 , APC , BRCA1/2 , PTEN
Mutator (DNA repair) genes Repair replication errors and DNA damage Defect → hypermutation → cancer Recessive at cellular level MLH1 , MSH2 , MSH6 , PMS2 (Lynch), BRCA1/2 (DSB repair)
Knudson's two-hit hypothesis applies to tumor suppressors: both alleles must be inactivated. In familial cases the first hit is inherited (germline) and the second is somatic, so tumors appear earlier and bilaterally. In sporadic cases both hits are somatic, so disease appears later and is usually unilateral. Retinoblastoma is the classic example.
Cell Cycle Checkpoints
The cell cycle (G1 → S → G2 → M) is governed by cyclins and cyclin-dependent kinases (CDKs) . Key checkpoints:
G1/S (restriction point) — controlled by the p16–cyclin D–CDK4/6–Rb–E2F axis. Rb (retinoblastoma protein) holds E2F inactive until phosphorylated by cyclin D–CDK4/6. p53 mediates G1 arrest after DNA damage by inducing p21 , which inhibits CDKs and blocks S-phase entry.
G2/M — governed by CDK1–cyclin B; verifies DNA replication completion and detects damage.
Spindle assembly checkpoint (M) — ensures all chromosomes are properly attached to spindle microtubules before anaphase.
p53 , called the guardian of the genome , is mutated in roughly 50% of all cancers . Loss of p53 disables DNA-damage-induced arrest and apoptosis, allowing damaged cells to divide.
Apoptosis
Apoptosis (programmed cell death) eliminates damaged or surplus cells. The intrinsic (mitochondrial) pathway : DNA damage → p53 → up-regulation of pro-apoptotic BAX and down-regulation of anti-apoptotic BCL-2 → mitochondrial outer-membrane permeabilization → cytochrome c release → caspase cascade (initiator caspase-9 → executioner caspases-3/6/7). The extrinsic pathway : death receptors (Fas, TNF receptor) → caspase-8 → executioner caspases. Evasion of apoptosis is a hallmark of cancer ; for example, BCL-2 overexpression from the t(14;18) translocation in follicular lymphoma blocks apoptosis and allows neoplastic B cells to accumulate.
Hallmarks of Cancer (Hanahan & Weinberg)
Sustained proliferative signaling (e.g., oncogenic RAS , growth-factor autocrine loops).
Evade growth suppressors (loss of RB1 , TP53 ).
Resist apoptosis (e.g., BCL-2 overexpression).
Enable replicative immortality via telomerase reactivation.
Induce angiogenesis (VEGF, FGF signaling).
Activate invasion and metastasis (EMT, matrix metalloproteinases).
Deregulate cellular energetics (Warburg effect — aerobic glycolysis).
Avoid immune destruction (PD-L1 expression, MHC downregulation).
Genome instability and mutation (repair defects, mutator phenotype).
Tumor-promoting inflammation (tumor-associated macrophages, cytokines).
Hereditary Cancer Syndromes
- Syndrome Gene Inheritance Associated cancers
- Li-Fraumeni TP53 AD Sarcoma, breast, brain, adrenocortical, leukemia
- Familial retinoblastoma RB1 AD Retinoblastoma, osteosarcoma
- Familial adenomatous polyposis (FAP) APC AD Hundreds of colon polyps; colon cancer by ~40 years
- Lynch syndrome (HNPCC) MLH1, MSH2, MSH6, PMS2 AD Colon, endometrial, ovarian, gastric
- Hereditary breast/ovarian cancer BRCA1, BRCA2 AD Breast, ovarian, prostate, pancreatic
- Cowden syndrome PTEN AD Breast, thyroid, endometrial
- von Hippel-Lindau VHL AD Hemangioblastoma, renal cell, pheochromocytoma
- MEN2 RET AD Medullary thyroid, pheochromocytoma, parathyroid
Lynch syndrome is a mutator phenotype — loss of mismatch repair produces microsatellite instability (MSI) , detectable by PCR or immunohistochemistry, and guides immunotherapy selection. FAP follows the adenoma–carcinoma sequence: an inherited APC allele plus somatic loss of the other allele initiates polyp formation; additional mutations in KRAS , TP53 , and others drive progression to carcinoma.
Tumor Heterogeneity and Evolution
Cancers evolve by clonal expansion and Darwinian selection : successive rounds of mutation yield subclones with different growth advantages, and therapy selects resistant clones. Driver mutations (in oncogenes and tumor suppressors) confer growth advantage, whereas passenger mutations are neutral byproducts of genomic instability. Intratumor heterogeneity — distinct subclones within one tumor — complicates treatment and drives resistance, which is why combination therapy targeting multiple pathways is often more durable than single-agent treatment.
Key Oncogenes and Tumor Suppressors: Gene-to-Cancer Map
Building on the category table above, the following pairings are high-yield because PA-CAT items commonly name a cancer and ask for the mutated gene, or vice versa. Memorize the gene, its class, and the signature cancer.
- Gene Class Associated cancer(s) Clinical note
- KRAS Oncogene Pancreatic, lung adenocarcinoma, colorectal Mutated in ~90% of pancreatic ductal adenocarcinomas
- HER2 (ERBB2) Oncogene Breast, gastric Amplification drives ~20% of breast cancers; target of trastuzumab
- MYC Oncogene Burkitt lymphoma, neuroblastoma Translocation t(8;14) under IgH enhancer in Burkitt
- BCL2 Oncogene Follicular lymphoma t(14;18) blocks apoptosis
- RB1 Tumor suppressor Retinoblastoma, osteosarcoma Knudson two-hit prototype
- APC Tumor suppressor Colorectal (FAP) Initiates adenoma–carcinoma sequence
- TP53 Tumor suppressor Li-Fraumeni; ~50% of all cancers Guardian of the genome
BRCA1/2 Tumor suppressor Breast, ovarian, pancreatic, prostate Homologous recombination repair; PARP inhibitor target
- VHL Tumor suppressor Clear-cell renal cell, hemangioblastoma Regulates HIF-1α under normoxia
- RET Oncogene (gain-of-function) Medullary thyroid, MEN2A/2B Activating mutation, unlike most tumor suppressors
Notice the asymmetry: oncogenes are activated by gain-of-function (amplification, point mutation, translocation to an active enhancer), whereas tumor suppressors are inactivated by loss-of-function (deletion, nonsense, frameshift). A useful PA-CAT shortcut: if the question names a translocation producing a fusion gene or constitutive activation (BCR-ABL, MYC-IgH, BCL2-IgH), think oncogene; if it describes loss of both alleles or a familial syndrome with bilateral tumors, think tumor suppressor.